AGIOS PHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Basic from 2019 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2023.
  • Agios Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 56.9M shares, a 2.04% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 55.7M shares, a 1.57% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 54.8M shares, a 9.36% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 60.4M shares, a 12.4% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 55.7M +862K +1.57% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 54.8M -5.66M -9.36% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 60.4M -8.55M -12.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 69M +9M +15% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 60M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.